Miao Su
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Nanocomposite Films for Food Packaging
Papers in
-
- RNA Interference and Gene Delivery 4
-
- Nanoplatforms for cancer theranostics 9
- Co-authors
- Edouard C. Nice (4 shared papers)Xianzhu Yang (9 shared papers)Wei Gao (1 shared paper)Peijie Wu (1 shared paper)Wenhui Zhang (1 shared paper)Jie Lin (1 shared paper)Na Xie (1 shared paper)Li Zhou (3 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Cancers (2 papers)RSC Advances (2 papers)Frontiers in Genetics (2 papers)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- ChinaAustraliaUnited Kingdom
In The Last Decade
Miao Su
40 papers receiving 579 citations
Peers
Comparison fields: 5 of 101
- Biomaterials 123
- Cancer Research 76
- Immunology 95
- Oncology 106
- Biomedical Engineering 169
Countries citing papers authored by Miao Su
This map shows the geographic impact of Miao Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miao Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miao Su more than expected).
Fields of papers citing papers by Miao Su
This network shows the impact of papers produced by Miao Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miao Su. The network helps show where Miao Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Miao Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 147 | |
| 2 | 2021 | 50 | |
| 3 | 2023 | 45 | |
| 4 | 2022 | 44 | |
| 5 | 2017 | 40 | |
| 6 | 2023 | 34 | |
| 7 | 2024 | 26 | |
| 8 | 2021 | 19 | |
| 9 | 2023 | 18 | |
| 10 | 2021 | 13 | |
| 11 | 2024 | 12 | |
| 12 | 2023 | 12 | |
| 13 | 2022 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2022 | 11 | |
| 16 | 2023 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2024 | 8 | |
| 19 | 2024 | 7 | |
| 20 | 2023 | 7 |
About Miao Su
Miao Su is a scholar working on Molecular Biology, Biomedical Engineering, Immunology, Biomaterials and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 590 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (4 papers), Immunotherapy and Immune Responses (4 papers), RNA Interference and Gene Delivery (4 papers), Advanced Nanomaterials in Catalysis (4 papers), Nanocomposite Films for Food Packaging (3 papers), Immune cells in cancer (3 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Biomaterials (123 citations), Cancer Research (76 citations), Immunology (95 citations), Oncology (106 citations) and Biomedical Engineering (169 citations). Miao Su has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Edouard C. Nice, Xianzhu Yang, Wei Gao, Peijie Wu, Wenhui Zhang, Jie Lin, Na Xie, Li Zhou, Canhua Huang and Junbin Chen. Their work appears in journals such as Frontiers in Oncology, Cancers, RSC Advances, Frontiers in Genetics and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.